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insulin extraction, elevated lipoprotein production, and increased gluconeogenesis [6] [7] [8] , all hallmarks of insulin resistance. However, the pathophysiological mechanism(s) responsible for increased portal NEFA production in visceral obesity remain to be clarified.
Insulin increases the storage of substrate molecules in adipose cells by modulating two main pathways; it stimulates glucose uptake and lipogenesis, and inhibits lipolysis. Most of the glucose incorporated into adipocytes in the presence of insulin is used for re-esterification of fatty acids [9] , but a significant proportion of glucose can also be released as lactate in large adipose cells [10, 11] . On the other hand, insulin is one of the most potent modulators of lipolysis and its antilipolytic effect is observed at low physiological concentrations (1-1000 pmol/l). Thus, the magnitude of insulin action on both glucose transport and lipolysis is believed to control, to a significant degree, the storage or net release of fatty acids by adipocytes [12] . Other important modulators of fatty acid turnover in adipose cells are catecholamines, through their a 2 -adrenoceptor-mediated inhibitory and their b -adrenoceptor-mediated stimulatory effects, as well as adenosine, a nucleotide released by fat cells that blunts both basal and stimulated lipolysis [12] . Site differences in the action of catecholamines, insulin, and adenosine on human adipose tissue lipolysis have already been shown in numerous studies [see (2, 7, 13) for reviews]. However, few studies have looked at possible differences in insulin action on glucose transport. Regional variation in insulin-stimulated glucose uptake has been reported in freshly isolated adipocytes [14] and newly differentiated cultured fat cells [15] obtained from epididymal, retroperitoneal, and dorsal subcutaneous tissues of rats. However, to the best of our knowledge, direct comparisons of insulin action between subcutaneous and intra-abdominal adipose regions have not yet been reported in either rats or humans.
Thus, the principal goal of the present study was to examine whether insulin action on glucose transport and antilipolysis are subjected to regional variations in morbidly obese individuals. Our working hypothesis was that deep abdominal fat cells may be less sensitive to insulin action on glucose transport and antilipolysis than subcutaneous adipocytes, thus contributing to enhance NEFA release in the portal circulation. The stimulatory effect of insulin on glucose transport and the antilipolytic response to the hormone were compared in adipocytes isolated from two intra-abdominal sites [round ligament (or properitoneal) and omental] and from the subcutaneous abdominal region. Furthermore, we have attempted to identify the molecular mechanisms responsible for the putative site differences in the effect of insulin on adipocyte glucose transport by measuring the expression of the insulin-responsive GLUT4 glucose transporter, the main transporter isoform of adipose cells. Our results reveal the presence of regional variation in both insulin action and GLUT4 transporter expression in adipocytes. Surprisingly, however, the most insulin-responsive and GLUT4-enriched fat depot was found to be the round ligament. The physiological implications of these findings are discussed.
Subjects and methods
Selection of patients. The subjects of the present study were nine massively obese premenopausal women undergoing biliopancreatic diversion at the Laval Hospital of Qué bec. None of the patients had evidence of chronic disease (diabetes mellitus, cardiomyopathy, or endocrine disorders). Their body weight was stable at the time of the study. No subject had been either on a diet or involved in a slimming programme during the previous 6 months. All the women were non-smokers and moderate alcohol consumers. They signed an informed consent document, and the study was approved by the medical ethics committee. Subjects had fasted overnight before adipose tissue removal. General balanced anaesthesia was induced by a shortacting barbiturate and maintained by fentanyl and a mixture of oxygen and nitrous oxide. The patients did not receive drugs acting on the autonomic nervous system or modifying catecholamine levels. Adipose tissue samples were obtained within less than 30 min from the following sites. As soon as the abdomen was opened, adipose tissue samples were obtained from three different sites: first, from the subcutaneous abdominal wall, second from the round ligament, and third from the greater omentum. These adipose locations were chosen as representative of three different anatomical regions: 1) the subcutaneous fat which is not in contact with the peritoneum; 2) the round ligament fat which is in contact with the peritoneum and is here considered as pro-peritoneal fat; 3) the omental (epiploic) fat which is located within the abdominal cavity. The two latter adipose tissues have been classified as intra-abdominal depots because of their anatomic association with the peritoneum and both are drained by the portal vein [16] .
Total body fat and regional fat distribution. Body density was determined by the underwater weighing technique [17] and percent body fat was derived from body density [18] . Pulmonary residual volume was measured using the helium dilution method [19] . Fat mass was obtained by multiplying percent body fat by body weight. Fat-free mass was calculated as total body weight minus fat mass. Waist and hip girths were measured following the procedures recommended at the Airlie Conference [20] and the ratio of the waist-to-hip circumferences was calculated.
Metabolic determinations. Blood samples were obtained from an antecubital vein in the morning after a 12-h fast. Plasma glucose and triglycerides were measured enzymatically, whereas plasma insulin was measured by radioimmunoassay using precipitation with polyethylene glycol, as previously described [21] .
Adipocyte isolation. After collection, adipose tissue was quickly transferred to the laboratory, in saline (0.9 % NaCl) 4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid (HEPES) (5 mmol/l) (pH 7.4) and used within a 15-min period. Adipocytes were isolated according to the method of Rodbell [22] in a Krebs-Ringer bicarbonate buffer (pH 7.4) containing 4 % bovine serum albumin (KRBA) and 5 mmol/l glucose, plus 1 mg/ml collagenase as already described [23, 24] . Digestion took place in a shaking water bath under a gas phase of 95 % O 2 and 5 % CO 2 , for 40 min at 37°C. The suspension was then filtered and the cellular filtrate obtained was rinsed 3 times with 5 ml of KRBA. Isolated adipocytes were finally resuspended in KRBA and used for determinations of glucose metabolism and lipolysis, as described in the following sections.
Glucose transport in isolated adipocytes. Glucose transport was determined using d -[ 14 C(U)]-glucose as previously described by Kashiwagi et al. [25] with minor modifications [26] Measurement of adipocyte lipolysis. Extracellular glycerol release was used as the indicator of adipocyte lipolysis and was determined as previously described (21) using a cell concentration of 500-1000 cells/100 m l. NADH concentration was measured by bioluminescence with a luciferase solution, using a 1251 LKB Wallac luminometer. Fat cell diameters were determined using a Leitz microscope equipped with a graduated ocular (Rockleigh, N. J., USA). Mean fat cell diameter was assessed from the measurement of at least 500 cells, and the density of triolein (0.915) was used to transform adipose cell volume into fat cell weight [23] . When the antilipolytic effect of insulin was investigated, the incubation buffer was supplemented with 5 m g/ml adenosine deaminase (ADA) to remove adenosine released in the incubation medium by isolated adipocytes. Insulin responsiveness (maximal antilipolytic response) was given as percent inhibition of ADA-stimulated lipolysis [(ADA values minus insulin (1 nmol/l) values divided by ADA values) × 100)] Sensitivity was considered as the drug concentration giving half-maximal antilipolysis (IC 50 ) and was evaluated by logarithmic conversion from each dose-response curve.
Isolation of adipose tissue membranes. Adipose tissue samples (50-100 mg) were homogenized in 10 volumes of ice-cold HE-PES-sucrose buffer (20 mmol/l HEPES, pH 7.4, 4 mmol/l EDTA, 250 mmol/l sucrose), containing a cocktail of freshly added protease inhibitors (200 mmol/l) (PMSF), 1 mmol/l leupeptin, 1 mmol/l pepstatin A, 10 mmol/l E64). The homogenates were centrifuged at 2000 g for 5 min at 4°C. The supernatant was carefully removed from both the pellet (cell debris and nuclei) and the fat cake then was centrifuged at 150 000 g for 90 min at 4°C. The membrane pellet was re-suspended in 100 m l of HEPES-sucrose buffer and protein concentrations were determined by the bicinconinic acid assay (Pierce, Rockford, IL, USA), using bovine serum albumin (BSA) as standard.
Electrophoresis and Western blotting. Membrane proteins (5 m g) were subjected to sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) on 7.5 or 10 % polyacrylamide gels as described by Laemmli [27] and electrophoretically transferred to polyvinylidene difluoride (PVDF) filter membranes for 2 h as previously described [28] . PVDF membranes were incubated for 1 h at room temperature with buffer I (50 mmol/l Tris-HCl, pH 7.4, 150 mmol/l NaCl) containing 0.04 % Nonidet P-40 and 0.05 % Tween-20 and 3 % BSA, followed by overnight incubation at 4°C with the specific anti-GLUT4 antibody. The PVDF membranes were then washed for 30 min, followed by a 1-h incubation with anti-rabbit immunoglobulin G conjugated to horseradish peroxidase in buffer I containing 1 % BSA. The PVDF membranes were washed for 30 min in buffer I, and the immunoreactive bands detected by the enhanced chemiluminescence method. In preliminary experiments using 10 % polyacrylamide gels, we found that the polyclonal anti-GLUT4 antibody reacted with two bands, probably representing different glycosylated forms of the GLUT4 protein. It is believed that both bands represent GLUT4 for the following reasons: 1) the same two bands were also observed when using the monoclonal anti-GLUT4 antibody 1F8 (East Acres Biologicals, Southbridge, Mass., USA); 2) both bands were protected when the polyclonal anti-GLUT4 antibody was pre-adsorbed with a peptide corresponding to the last 20 amino acids of the carboxyl terminus region of GLUT4 (Marette et al., unpublished observation). In following experiments, 7.5 % polyacrylamide gels were used to optimize the resolution of these two bands. Autoradiographs were quantitated by laser scanning densitometry using the "BioImage-Visage 110S" software from Millipore Corporation (Ann Arbor, Mich., USA). A control membrane sample was run on every gel and used for comparing samples from different gels.
RNA extraction and determination of GLUT4 mRNA. GLUT4 mRNA levels were determined using a semi-quantitative polymerase chain reaction (PCR) approach, as previously described [29] . Glyceraldehyde phosphate dehydrogenase (GAPDH) mRNA was also measured and was used as a control for the reverse transcriptase (RT)-PCR assay [30] . In preliminary studies, we have verified that GAPDH mRNA was expressed at similar levels in different human adipose depots as well as in various rat tissues such as the brain, heart, skeletal muscle, and liver (data not shown). Total cellular RNA from 50-100 mg of human adipose tissue was purified using guanidium thiocyanate-phenol-chloroform extraction [31] . Can.). Sequences of the antisense and sense oligonucleotides were as follows: 5′-CAAATAGAAGGAAGACGTAG-3′ and 5′-CATAGGAGCTGGTGTGGTCA-3′ for GLUT-4 and 5′-AGATCCACAACGGATACATT-3′ and 5′-TCCCTCAA-GATTGTCAGCAA-3′ for GAPDH. The expected sizes of amplification products were 382 base pairs (bp) for GLUT4 and 331 bp for GAPDH. In preliminary experiments with adipose tissue RNA ranging from 100-1000 ng, it was verified that both GLUT4 and GAPDH are amplified linearly using the above PCR conditions. Moreover, the identity of the amplified products was confirmed by the ability of restriction enzymes to yield DNA fragments corresponding to the expected sizes for GLUT4 and GAPDH (data not shown).
Amplification products were run in 12 % acrylamide gels, stained in ethidium bromide and fluorescence associated with DNA bands was measured using a scanner BioImage-Visage 110S from Millipore Corporation. In some experiments, [a-32 P]dCTP-labelled GLUT4 and GAPDH DNA bands on dried acrylamide gels were exposed to X-ray films for densitometric analysis. Since we found very similar results whether GLUT4/ GAPDH ratios were determined from scanning ethidium bromide or 32 P-labelled bands, only the former quantification was used in the present study.
Drugs and chemicals. D-[
14 C(U)]-glucose (Specific activity: 360 mCi/mmol) was purchased from New England Nuclear (Boston, Mass., USA). Collagenase, BSA, ADA, and enzymes for glycerol assays were obtained from Boehringer. Insulin (Iletin II) (500 IU/ml) came from Eli Lilly (Indianapolis, Ind., USA). The polyclonal GLUT4-specific antibody (IRGT) was obtained from East Acres Biologicals. Anti-rabbit immunoglobulin G conjugated to horseradish peroxidase and reagents for chemiluminescence detection were purchased from Amersham (Oakville, Ontario, Canada). All other chemicals were of the highest purity grade commercially available.
Statistical analysis. The overall regional difference effect was first tested by analysis of variance and multiple comparisons among the three fat depots were handled with the post-hoc Fisher's protected least-squares difference test. Relationships between two variables were evaluated by Pearson's correlation coefficient.
Results
The subjects' characteristics are summarized in Table 1. These women were severely obese, as shown by the mean percentage of body fat (58 ± 5 %) and body mass index values (reaching 45 ± 5 kg/m 2 ).
Furthermore, the mean waist-hip ratio of 0.84 ± 0.06 indicated that these patients tended to show a high proportion of abdominal adipose tissue. As expected, fasting insulin levels were elevated as compared to those observed in moderately obese premenopausal women of similar age [32] . However, fasting glycaemia and triglyceridaemia were quite normal or only slightly elevated. Total plasma cholesterol, as well as LDL-and HDL-cholesterol levels were within the normal range in these massively obese women (data not shown).
Effects of insulin on glucose transport and lipolysis.
The effects of insulin on glucose transport in Figure 1 . Basal and insulin-stimulated glucose transport rates varied quite significantly between subjects (Fig. 1A) . The difference in absolute rates of transport between the subjects or within each cell type was not related to variation in cell surface area (see legend to Fig. 1 ). Basal glucose transport tended to be greater in omental fat cells as compared to adipocytes from the other depots. Insulin stimulated glucose transport in a dose-dependent fashion in cells from all adipose regions, with maximal (2-3 times) increases at 10 -9 -10 -8 mmol/l (Figs. 1A and B). When insulin action was expressed as percent stimulation above basal in order to correct for interindividual variation in basal glucose transport rates, maximal insulin stimulation (observed at 10 -9 -10 -8 mmol/l) was significantly higher in round ligament fat cells as compared to omental and subcutaneous adipocytes (Fig. 1B) . The sensitivity of round ligament adipose cells to insulin also tended to be greater than that observed in the other fat cells, although the difference failed to reach statistical significance (p = 0.13). The half-maximal effective dose of insulin (EC 50 ) was 0.38 ± 0.16 nmol/l for round ligament adipocytes as compared to 1.12 ± 0.35 nmol/l and 0.91 ± 0.25 nmol/l for subcutaneous and omental adipose cells, respectively.
In addition to glucose transport, regional variation was also found for the inhibitory action of insulin on adipocyte lipolysis. As shown in Figure 2 , the ability of insulin to inhibit ADA-stimulated glycerol release was higher in round ligament adipocytes (p < 0.005) as compared to the other adipose cells (Fig. 2A) . However, in subcutaneous fat cells, insulin inhibition of lipolysis was still significantly higher than that observed in omental adipocytes (p < 0.005). Furthermore, insulin sensitivity for inhibition of lipolysis was greater in round ligament adipocytes than in either subcutaneous or omental fat cells (p < 0.01) (Fig. 2B ).
GLUT4 expression in adipose tissues.
We further investigated whether regional differences in insulin action on glucose metabolism may be related to a differential expression of the GLUT4 glucose transporter in adipose cells from the three depots. Total adipose tissue membranes were isolated and equivalent amounts of proteins were resolved on SDS-PAGE. Immunoblotting was performed using a GLUT4-specific polyclonal antibody. A representative Western blot is shown in Figure 3A . The GLUT4 protein migrated as a double band of about 46 and 48 kDa (see Methods) in membranes isolated from all fat depots as well as in a rat skeletal muscle membrane sample used as an internal control for gel comparisons. Relative GLUT4 protein levels were 5 times and 2.2 times (Fig. 3B) . No significant difference in GLUT4 abundance was found between the two latter depots. Similar results were obtained when the relative amounts of either the lower or the upper GLUT4 bands were analysed separately (data not shown).
When sufficient amounts of adipose tissue were removed (n = 6-8), we also assessed the expression of the GLUT4 gene in the different regions by measuring GLUT4 mRNA levels. GAPDH mRNA levels assessed in the same samples were used as internal controls for the RT-PCR assay. A representative experiment is shown in Figure 4A . GLUT4 and GAPDH were both amplified as single gene products migrating at the expected molecular size (GLUT4: 382 bp, GAPDH: 331 bp) on agarose gels. GLUT4/GAPDH ratios were calculated and the average values are presented in Figure 4B . Round ligament adipose tissue showed higher GLUT4 mRNA levels than subcutaneous and omental fat depots (p < 0.01). GLUT4 mRNA levels were not significantly different between the two latter adipose regions. It is interesting to note that a significant positive relationship (r = 0.63, p < 0.005) was observed between GLUT4 protein and mRNA levels in the adipose tissue samples in which both parameters could be determined.
Relationship of GLUT4 expression with the subject's metabolic characteristics. Adipose GLUT4 mRNA levels were positively associated with both fasting insulinaemia and glycaemia, although some associations failed to reach statistical significance (Table 2) . In contrast, no relationship was observed between GLUT4 protein amounts and fasting plasma insulin or glucose levels, with the exception of the round ligament adipose depot in which the transporter protein was associated with fasting insulinaemia. No significant relationship was found between GLUT4 mRNA or protein levels and triglyceride levels (Table 2) . Furthermore, GLUT4 protein levels were correlated with neither fat mass, percent body fat nor with the body mass index (Table 2) . However, these adiposity indices were positively associated with GLUT4 mR-NA levels determined in round ligament adipose tissue but not in the other depots. Interestingly, amounts of GLUT4 protein were strongly (p < 0.01) and negatively correlated with the waist-to-hip ratio in all depots investigated.
Discussion
The present results show that insulin stimulates glucose transport in human adipocytes isolated from three different anatomical locations. The stimulation of glucose transport by insulin in this study (2-3-fold) is less important than that commonly reported in rat adipocytes (10-20-fold) [see [33] for review] but similar to that found in previous studies using human fat cells [25, 34, 35] . This apparent discrepancy is unlikely to be explained by methodological differences in adipocyte isolation since the magnitude of the antilipolytic effect of insulin was comparable to that observed in rat adipocytes. The species-related difference in insulin action on glucose transport has been recently reported to be related to a lower number of intracellular GLUT4 transporters to be recruited to the cell surface in human adipocytes, as a consequence of their larger size [36] . Indeed, the large human fat cells appear to have a greater proportion of cell surface GLUT4 in the basal state than the smaller rat adipocytes, presumably in order to meet greater metabolic needs. Although differences in fat cell size may explain inter-species variation in insulin responsiveness, they cannot account for the regional variations observed in the present study. Indeed, the more insulin responsive round ligament adipocytes were larger than subcutaneous and omental fat cells (Fig. 1) . Differences in GLUT4 expression, rather than fat cell size, appear to be responsible for the regional variations in insulin action on glucose transport (see below). When considering absolute values, glucose transport was apparently lower in round ligament fat cells, both in the basal and insulin-stimulated states (Fig. 1A) . However, we found very important interindividual variations in the absolute rates of glucose transport in these subjects and we could not detect significant differences in absolute basal or insulinstimulated glucose transport rates between the fat cell types. In fact, insulin failed to significantly stimulate basal glucose transport in subcutaneous and omental fat cells when considering absolute values. However, when insulin action was expressed relative to the basal transport rate, these variations among subjects were greatly diminished and this allowed a better evaluation of insulin action among fat cell types (Fig. 1B) . The per cent insulin stimulation was always higher for round ligament fat cells, and importantly, even in those patients where basal transport rates were comparable between fat cell types.
It is well known that glucose transport in adipose cells is mainly facilitated by the GLUT4 glucose transporters. Previous studies performed in normal and diabetic subjects have shown that insulin action on adipocyte glucose transport is associated with GLUT4 expression [37] . Our data further suggest that a differential expression of GLUT4 is responsible, at least in part, for the regional differences in adipocyte insulin action. Indeed, we found that round ligament adipocytes exhibited higher levels of GLUT4 as compared to the two other cell types. Similar to the GLUT4 protein abundance, GLUT4 mR-NA levels were significantly greater in round ligament than in subcutaneous and omental adipose tissues, suggesting that variations in GLUT4 transcription could account for a large part of the site differences found in GLUT4 protein content. Differences in insulin-induced GLUT4 translocation may also contribute to the observed regional variations in insulin responsiveness. However, this hypothesis could not be verified in the present study because of the relatively small amount of tissue available.
In addition to its stimulatory effect on glucose transport, the ability of insulin to inhibit ADA-stimulated lipolysis was also assessed. Insulin-induced antilipolysis was also found to vary between fat cell types. Insulin blunted lipolysis to a greater degree in subcutaneous abdominal than in omental fat cells (Fig. 2) , confirming previous studies performed in moderately obese subjects [38] . Furthermore, as for glucose transport, round ligament fat cells showed the greatest sensitivity and responsiveness to the hormone. The fact that site differences in insulin action were not limited to glucose transport suggests the presence of regional variations at more proximal insulin signalling events in human adipocytes. Furthermore, round ligament adipose cells were not only more responsive but also more sensitive to insulin, suggesting that differences in insulin receptor number and/or affinity may also exist between these fat cell types. In this regard, variations in insulin receptor affinity [38] , as well as in its autophosphorylation and tyrosine kinase activities [15] have been previously reported between adipocytes isolated from different regions. Further studies are required to determine whether differences in insulin receptor number and/or functional activities may also contribute to the greater insulin action on both glucose transport and lipolysis in round ligament adipose cells.
An unexpected finding in the present study was that regional variation in insulin-stimulated glucose transport was observed between adipocytes isolated from two intra-abdominal depots. Indeed, adipocytes from the round ligament were more insulin responsive than cells from the omental region. The physiological basis for the observed functional heterogeneity in insulin action among intra-abdominal adipose depots is still unclear. It has been proposed that an abnormally elevated release of NEFA by the enlarged deep abdominal adipose tissue may explain the association reported between visceral obesity and insulin resistance. Accordingly, studies conducted on both humans and animals have already shown that visceral fat cells are lipolytically more active than subcutaneous adipocytes [see [2, 7, 13] for reviews]. The greater lipolysis of omental fat cells appears to be related to the weaker antilipolytic actions of both insulin and adrenaline (a 2 -adrenoceptor-component), as well as to the higher lipolytic effect of catecholamines (b-adrenoceptor pathway) when compared to other fat cell types [24, [38] [39] [40] [41] [42] [43] . However, the present study indicates that in contrast to omental adipose cells, intra-abdominal round ligament adipocytes are unlikely to release high levels of NEFA in the portal circulation but are rather efficient in storing triglycerides. Based on the subjects' plasma insulin levels (Table 1) , round ligament adipocyte lipolysis would be largely inhibited in vivo, even in the fasting state. Moreover, we have recently reported that lipoprotein lipase activity is higher but that the lipolytic sensitivity to adrenaline is reduced in round ligament cells as compared to omental cells [24] , explaining the greater fat cell weight of the former cell type. Furthermore, most of the glucose taken up by adipose cells in the presence of insulin is used for re-esterification of fatty acids, hence reducing their net release in the circulation. Since round ligament fat cells show the greatest responsiveness to insulin, it appears plausible that a large part of the glucose extracted by these cells could be used for re-esterification of fatty acids. Furthermore, since properitoneal fat (i. e. the round ligament) is quantitatively much more important than the intraperitoneal fat of the omentum, the increased insulin responsiveness of round ligament adipose cells may be physiologically relevant from a quantitative point of view. In future studies, we will attempt to determine the relative contribution of properitoneal fat cells to total body fat mass (i. e. by computed tomography) in order to evaluate more precisely its physiological impact and whole-body glucose and lipid homeostasis.
Taken together, our results suggest that round ligament fat cells may serve to limit the impact of intraabdominal obesity on insulin resistance by reducing the release of NEFA in the portal vein. In this regard, it is interesting to note that the subjects' metabolic profile was not overtly deteriorated (Table 1) , despite the severity of their obesity. On the other hand, it is also important to note that the regional variation in adipocyte insulin action described in the present study was observed in morbidly obese premenopausal women. Whether such differences also occur in normal lean individuals or are linked to the development of an obese state and its associated complications is still unknown.
Despite the existence of regional variation in adipose tissue GLUT4 expression, abdominal obesity (crudely assessed by the waist-hip ratio) was negatively correlated with GLUT4 protein content in all adipose regions investigated. However, no significant association was found between adipose GLUT4 protein abundance and the waist circumference, probably a better index of visceral obesity in these morbidly obese women [44] . We have recently proposed that the waist-hip ratio may represent an index of the relative accumulation of abdominal adipose tissue, independently from the degree of obesity [44] . Thus, GLUT4 protein levels may be associated with the distribution of adipose tissue in the abdominal region rather than with the absolute amount of visceral fat. More direct assessment of intra-abdominal adipose mass by computed tomography may help resolve this issue in further studies.
In summary, the present study shows the existence of regional variations in adipose tissue insulin action in morbidly obese women. The greater insulin action on glucose transport in round ligament adipocytes is associated with a higher expression of GLUT4 when compared to subcutaneous and omental fat cells. The greater expression of GLUT4 in round ligament adipose tissue appears to be mainly explained by a higher transcription of the GLUT4 gene although post-transcriptional mechanisms cannot be ruled out.
